共查询到20条相似文献,搜索用时 46 毫秒
1.
鼻出血是病理条件下人体最多见的出血[1],是耳鼻喉科最常见的急症,老年人常患高血压、动脉硬化及伴各个器官不同程度的功能衰退,而且多数患者恐惧死亡引起精神紧张,了解老年人生理及心理特点,提高防范,快速有效施治非常必要,现将我院2004年1月~2006年12月诊治的严重老年人鼻出血38例总结如下。 相似文献
2.
张建明 《中国医药工业杂志》2008,39(2):146-151
通过参考2007年1~11月医药行业统计数据,对全国医药行业经济运行情况进行了分析。结果显示,全国医药行业生产、销售保持快速增长,但产销率下降,出口增速减缓。虽然成本费用在提升,但经济效益出现了大幅度提升。 相似文献
3.
冠心病在社区中是老年人群最常见的慢性疾病之一,如何来采取行动,以减慢和抑制这一慢性病上升的趋势已成为当务之急. 由中国医师协会和上海和黄药业共同发起的"心希望工程",自2007年3月正式启动以来,已在北京、上海以及浙江、江苏、广东、辽宁、山东等地的大、中城市取得了良好的社会反响. 相似文献
4.
乔治·海德姆有了中国名儿 乔治·海德姆1910年9月生于美国纽约州水牛城一个阿拉伯移民家庭,祖籍黎巴嫩.他的父亲是个工人.乔治·海德姆靠奖学金资助完成了学业.1933年,23岁的他毕业于瑞士日内瓦医科大学,并获博士学位.受时代的影响,他毕业后就来到中国,结识了宋庆龄等人,因此得以在1936年和斯诺一起来到陕北. 相似文献
5.
5月12日,四川省汶川地区发生强烈地震以后,作为国家战备药品储备基地、军队战备药材代储企业的上海市医药股份有限公司,在国家重大突发事件面前,表现出高度的社会责任感,迅速启动了药品应急供应绿色通道,截至5月13日下午4点,已经送出第一批急救药品887件,并向上海市红十字会捐赠急救药品(价值人民币87.48万元). 相似文献
6.
杰出的社会活动家、著名爱国人士、香港知名实业家、全国政协副主席霍英东先生于2006年10月28日在北京逝世,享年83岁.霍英东先生生前与癌症斗争了23年多,他的精神值得大家学习.霍英东先生是香港著名的大企业家,他热爱祖国,乐善好施,经常慷慨捐资救灾或为国家、社会、民众办好事和实事. 相似文献
7.
目的:探讨丙酮酸对大鼠糖尿病性白内障的抑制作用.方法:Wistar大鼠120只,随机分为对照组、模型组及治疗组3组.模型组、治疗组应用链脲佐茵(STZ)诱发糖尿病.治疗组饲料及饮水中添加2%丙酮酸钠.在实验4、8、12周观察3组大鼠晶状体组织中GSH、MDA以及ATP的变化.结果:模型组与对照组比较,晶状体组织中GSH及ATP含量明显下降,MAD水平升高.而治疗组上述指标有不同程度改善.结论:丙酮酸减轻氧化应激反应,改善晶状体的能量代谢,抑制糖尿病性白内障的发生. 相似文献
8.
9.
10.
11.
12.
目的 探讨外伤所致鼻骨骨折患者在鼻内镜下行鼻骨骨折整合与鼻中隔矫正术较传统鼻中隔黏膜下矫正术的优势.方法 选取2014年2月至2017年1月本院耳鼻喉科收治的鼻外伤所致鼻骨伴鼻中隔骨折患者78例进行研究,根据患者手术方式分为A组(鼻内镜下鼻骨骨折整合与鼻中隔矫正术,42例)和B组(传统鼻中隔黏膜下矫正术,36例),比较两组患者手术时间、术后疼痛、住院时间及临床疗效.结果 A组患者手术时间长于B组[(78.6±26.4)min比(51.8±14.9) min],术后1d疼痛评分、住院时间少于B组[(3.1±0.6)比(3.9±0.5),(6.4±1.2)d比(7.9±1.6)d],差异有统计学意义(P<0.05).A组患者治疗效果优于B组(97.62%比80.56%,P< 0.05).结论 外伤所致鼻骨伴鼻中隔骨折患者在鼻内镜下行鼻骨骨折整合与鼻中隔矫正术,相对传统手术可减轻患者手术创伤,提高手术疗效. 相似文献
13.
《中国医药科学》2016,(6):206-208
目的分析经鼻内窥镜下鼻中隔穿孔修补术治疗鼻中隔穿孔的临床效果。方法选取2011年2月~2013年2月收治于我院的40例鼻中隔穿孔患者作为研究对象,并根据术式不同分为观察组和对照组,观察组20例,行双旋转鼻中隔黏膜瓣修补术;对照组20例,行颞肌、骼前上棘阔筋膜修补术。两组手术均经鼻内窥镜下进行,对比两种术式的修复效果。结果观察组患者无需拆线,所有患者呈Ⅰ期愈合,鼻腔通气全部恢复到正常水平,且无再穿孔现象出现。对照组患者需拆线,术后2年有4例患者发生阔筋膜干燥脱落而引发再穿孔,14例患者鼻腔通气恢复到正常水平。结论鼻中隔穿孔患者的修补术式中,双旋转鼻中隔黏膜瓣修补鼻中隔穿孔,其治愈率高、生长效果良好。 相似文献
14.
A G Palma-Carlos M L Palma-Carlos N Rombaut 《International journal of clinical pharmacology research》1988,8(1):25-30
The effect of levocabastine, a new specific H1 antagonist, has been investigated against a placebo in nasal provocation tests on 42 allergic patients divided into two parallel groups. The results obtained show that it significantly inhibited the nasal reaction to the allergen and seems to have a long-lasting effect in allergic patients. 相似文献
15.
Yumu?han Günay Fatih Uygur Arzu Atay Bahattin ?elik?z 《Central European Journal of Medicine》2010,5(2):257-260
Severe and composite defects of the nose due to trauma or excision of neoplasms can cause significant functional and aesthetic
problems. It has been known that nasal stents have been used to maintain the nasal patency and nostril shape for a long time.
Recently, nasal prosthesis was introduced as a method to solve aesthetic problems of the patients who had an amputated nose.
In the present study, nasal prosthesis combined with nazal stents was used to camouflage the nasal disfigurement and to maintain
the nasal patency in two adult female patients. Functional and aesthetic results was accepted as satisfactory by both the
patients and the physicians. 相似文献
16.
眼镜蛇神经毒素粉末剂的鼻黏膜纤毛毒性考察 总被引:2,自引:0,他引:2
目的:考察浙江产眼镜蛇神经毒素鼻用粉末剂(神经毒素粉剂)的鼻黏膜纤毛毒性。方法:以在体蟾蜍上腭模型,观察神经毒素粉剂对鼻纤毛摆动的影响;运用组织病理学方法,在给于家兔神经毒素粉剂后1,3,5,7d时,取鼻中隔黏膜进行光学显微镜观察。结果:神经毒素粉剂抑制鼻纤毛摆动强度,但停止用药后8~9h纤毛摆动可完全恢复,且纤毛形态无明显改变;家兔给予神经毒素粉剂后1,3,5d,其鼻中隔黏膜与空白对照组差异无显著性。第7天,黏膜上皮松化,黏膜轻度充血,但基底膜完整。结论:神经毒素粉剂无急性不可逆性鼻黏膜纤毛毒性。 相似文献
17.
18.
The Ussing chamber diffusion system was used as a model to study the apparent permeability across porcine nasal mucosa of eight drugs and molecules with different physicochemical characteristics, namely insulin, lidocaine, nicotine, PEG 4000, propranolol, sumatriptan, melagatran and an amino diether. A weak correlation was found between the apparent permeability coefficients and the corresponding literature data on the fraction absorbed after nasal administration in humans. In the case of passively transported drugs, a closer correlation was found than for the substances where other mechanisms such as carrier-mediated transport or possible efflux were involved. Factors influencing the correlation between in vitro and in vivo data are discussed and the importance of electrophysiological control of the viability status of the excised mucosa is emphasised. Although caution has to be exercised in view of the limitations of the in vitro system, it seems to be a useful tool when evaluating different factors influencing permeability of nasal mucosa. 相似文献
19.
OBJECTIVE: To conduct a cost-effectiveness study of nasal budesonide versus surgical treatment in the management of nasal polyps. DESIGN AND METHODS: A decision-tree model reflecting two different treatment strategies for nasal polyps in Sweden was developed. The first strategy was initial polypectomy, performed under three different sets of circumstances: inpatient functional endoscopic surgery, outpatient evulsion with sedation, or outpatient evulsion with local anaesthesia; all treatments were followed by intranasal treatment with budesonide (Rhinocort) 128 microg twice daily. The second strategy was initial intranasal treatment with budesonide 128 microg twice daily. PERSPECTIVE: Healthcare provider perspective. OUTCOME MEASURES AND RESULTS: After 1 month, treatment with nasal budesonide was classified as a success (82.5%) or a failure (17.5%) based on clinical study data. In cases of success, the treatment was continued, and in cases of failure, polypectomy was undertaken, followed by budesonide 128 microg twice daily. Treatments were evaluated after 4 months using prices from the Central Hospital in Sk?vde, Sweden. The expected reduction in cost from using initial nasal budesonide treatment compared with the different alternatives of polypectomy were 9760 Swedish kronors (SEK) for inpatient functional endoscopic surgery, SEK2747 for outpatient evulsion with sedation, and SEK672 for outpatient evulsion with anaesthesia (1998 values). Nasal budesonide 128 microg twice daily treatment for nasal polyps revealed a potential reduction in costs of 53% compared with the primary surgery approach. CONCLUSION: Initial treatment of nasal polyps with nasal budesonide provides lower costs than treatment with initial polypectomy with maintained effectiveness. 相似文献